Description
The global Hemoglobin Testing Devices Market was valued at USD 4065.44 Million in 2021 and is expected to reach USD 6195.63 Million by the end of 2028, growing at a CAGR of 5.92% during the forecast period of 2022-2028. The hemoglobin testing devices market is cast to notice substantial growth because of the rising prevalence of anemia cases. Anemia is a prominent public health issue that influences developed and developing nations. According to statistics, nearly 1.6 billion people are suffering from anemia globally. As a result, several federal bodies across the globe have commenced executing state-wide initiatives to spread attention about the ill consequences of anemia. Such endeavors could hugely help the hemoglobin testing devices market in the future.
What are Hemoglobin Testing Devices?
Hemoglobin is a known iron-based metalloproteinase in the red blood cells of humans. Its key procedure is to transport oxygen from the lungs to the rest of the body. A hemoglobin test estimates the level of hemoglobin or counts the red blood cells (RBC) in blood. These tests are operated extensively by physicians and doctors to diagnose any therapeutic conditions in the patient. If the test results depict a lower hemoglobin concentration in the bloodstream, it implies higher chances of patients being anemic. The growing prevalence of anemia across the globe is a major factor augmenting hemoglobin testing devices industry growth.
